Summary
This 2019 narrative review by den Hartigh consolidates evidence on conjugated linoleic acid (CLA), a naturally occurring fatty acid in ruminant-derived foods, and its purported anti-carcinogenic, anti-obesogenic, and anti-atherogenic properties. The review demonstrates that whilst pre-clinical studies in mice show substantial efficacy, human trial evidence is more modest and context-dependent. The paper discusses potential mechanisms of CLA action, including gut microbiota-mediated pathways, highlighting the translational gap between robust animal model findings and clinically meaningful outcomes in human populations.
Regional applicability
Given that CLA is naturally present in UK dairy and beef products from grass-fed systems, these findings are relevant to UK nutritional and public health policy, particularly regarding obesity and cardiovascular disease prevention. However, the modest efficacy observed in human trials suggests that dietary CLA alone is unlikely to provide standalone weight management benefits without accompanying lifestyle modifications.
Key measures
Body weight and composition changes; tumour incidence and markers; atherosclerosis and cardiovascular disease markers; lipid profiles; mechanistic pathways including gut microbiota composition
Outcomes reported
The review synthesised pre-clinical and human trial evidence on CLA's efficacy against obesity, cancer, and atherosclerosis, and examined potential physiological mechanisms including gut microbiota-mediated effects. Outcomes included weight loss, tumour incidence, atherosclerosis markers, and lipid profiles across animal models and human populations.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.